Boston Scientific Buys EndoTex

Boston Scientific Corp. (NYSE: BSX) has acquired EndoTex Interventional Systems Inc., a Cupertino, Calif.-based carotid artery stent maker. No financial terms were disclosed. Endotex had raised over $25 million in total VC funding, plus a late strategic infusion from Boston Scientific. Other shareholders included Delphi Ventures, Guidant Corp., New Enterprise Associates, New Venture Partners, Onset Ventures, US Surgical and Saratoga Ventures. www.bostonscientific.com www.endotex.com